Increase in Valproic Acid Levels During Riluzole Treatment in an Adolescent with Autism

This publication has 23 references indexed in Scilit:

• An Open-Label Trial of Riluzole, a Glutamate Antagonist, in Children with Treatment-Resistant Obsessive-Compulsive Disorder
  Journal of Child and Adolescent Psychopharmacology, 2007
• Brief Report: Exposure and Response Prevention for Obsessive Compulsive Disorder in a 12-year-old with Autism
  Journal of Autism and Developmental Disorders, 2007
• Treating Anxiety Disorders in Children with High Functioning Autism Spectrum Disorders: A Controlled Trial
  Journal of Autism and Developmental Disorders, 2006
• Contribution of CYP2C9, CYP2A6, and CYP2B6 to Valproic Acid Metabolism in Hepatic Microsomes from Individuals with the CYP2C9*1/*1 Genotype
  Toxicological Sciences, 2006
• Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial
  Biological Psychiatry, 2005
• Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder
  International Journal of Neuropsychopharmacology, 2005
• Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences
  Journal of Child and Adolescent Psychopharmacology, 2005
• A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism
  Neuropsychopharmacology, 2004
• A Double-blind Comparison of Clomipramine, Desipramine, and Placebo in the Treatment of Autistic Disorder
  Archives of General Psychiatry, 1993
• Differential response of seven subjects with autistic disorder to clomipramine and desipramine
  American Journal of Psychiatry, 1992